Journal article
Epigenetic programming defines haematopoietic stem cell fate restriction
- Abstract:
- Haematopoietic stem cells (HSCs) are multipotent, but individual HSCs can show restricted lineage output in vivo. Currently, the molecular mechanisms and physiological role of HSC fate restriction remain unknown. Here we show that lymphoid fate is epigenetically but not transcriptionally primed in HSCs. In multi-lineage HSCs that produce lymphocytes, lymphoid-specific upstream regulatory elements (LymUREs) but not promoters are preferentially accessible compared with platelet-biased HSCs that do not produce lymphoid cell types, providing transcriptionally silent lymphoid lineage priming. Runx3 is preferentially expressed in multi-lineage HSCs, and reinstating Runx3 expression increases LymURE accessibility and lymphoid-primed multipotent progenitor 4 (MPP4) output in old, platelet-biased HSCs. In contrast, platelet-biased HSCs show elevated levels of epigenetic platelet-lineage priming and give rise to MPP2 progenitors with molecular platelet bias. These MPP2 progenitors generate platelets with faster kinetics and through a more direct cellular pathway compared with MPP2s derived from multi-lineage HSCs. Epigenetic programming therefore predicts both fate restriction and differentiation kinetics in HSCs.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 13.3MB, Terms of use)
-
- Publisher copy:
- 10.1038/s41556-023-01137-5
Authors
- Publisher:
- Springer Nature
- Journal:
- Nature Cell Biology More from this journal
- Volume:
- 25
- Pages:
- 812–822
- Publication date:
- 2023-05-01
- Acceptance date:
- 2023-03-22
- DOI:
- EISSN:
-
1476-4679
- ISSN:
-
1465-7392
- Language:
-
English
- Keywords:
- Pubs id:
-
1339454
- Local pid:
-
pubs:1339454
- Deposit date:
-
2023-05-01
- ARK identifier:
Terms of use
- Copyright holder:
- Meng et al
- Copyright date:
- 2023
- Rights statement:
- © The Author(s), under exclusive licence to Springer Nature Limited 2023
- Notes:
- For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission.
If you are the owner of this record, you can report an update to it here: Report update to this record